Addex Therapeutics (ADXN) Other Operating Expenses (2022 - 2024)
Historic Other Operating Expenses for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $7.5 million.
- Addex Therapeutics' Other Operating Expenses fell 894.52% to $7.5 million in Q4 2024 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 894.52%. This contributed to the annual value of -$219040.1 for FY2024, which is 157395.52% down from last year.
- Latest data reveals that Addex Therapeutics reported Other Operating Expenses of $7.5 million as of Q4 2024, which was down 894.52% from $8.2 million recorded in Q4 2023.
- In the past 5 years, Addex Therapeutics' Other Operating Expenses ranged from a high of $17.3 million in Q4 2022 and a low of -$0.0 during Q1 2022
- Its 3-year average for Other Operating Expenses is $5.5 million, with a median of $3.7 million in 2023.
- Data for Addex Therapeutics' Other Operating Expenses shows a peak YoY increase of 7500.0% (in 2023) and a maximum YoY decrease of 5242.99% (in 2023) over the last 5 years.
- Over the past 3 years, Addex Therapeutics' Other Operating Expenses (Quarter) stood at $17.3 million in 2022, then tumbled by 52.43% to $8.2 million in 2023, then dropped by 8.95% to $7.5 million in 2024.
- Its last three reported values are $7.5 million in Q4 2024, $8.2 million for Q4 2023, and -$0.0 during Q2 2023.